Depression could shorten cancer survival, study suggests

August 2, 2012
Depression could shorten cancer survival, study suggests
Screening for mental health should be part of standard care, experts say.

(HealthDay) -- Symptoms of depression are linked to shorter survival times among cancer patients, according to a new study.

The link may be attributed to abnormal stress hormone regulation and inflammatory , researchers from the University of Texas M.D. Anderson Cancer Center reported in the Aug. 1 edition of PLoS ONE.

"Our findings, and those of others, suggest that mental health and social well-being can affect biological processes, which influence cancer-related outcomes," Lorenzo Cohen, a professor in the center's departments of general oncology and , and director of the Integrative Medicine Program, said in a university news release.

The findings "also suggest that screening for mental health should be part of standard care because there are well-accepted ways of helping people manage distress, even in the face of a life-threatening illness," Cohen added.

In conducting the study, the researchers analyzed surveys completed over a five-year period by 217 patients newly diagnosed with that had spread. The participants answered questions about how religious and spiritual they were. They were also asked about their symptoms of depression, social support, quality of life and .

The patients also provided as well as five saliva samples daily for three days. The researchers used the saliva samples to track changes in the patients' levels of cortisol, a stress hormone that is usually high in the morning before dropping throughout the day.

At the time of the analysis, 64 percent of the patients had died. The average amount of time these patients survived after being diagnosed was 1.8 years.

Overall, the study revealed that 23 percent of patients were clinically depressed. Even after taking other disease-related risk factors into account, the investigators noted that depression was associated with shorter survival time. Moreover, the study showed that higher than usual throughout the day were also linked to shorter survival among the .

Using tissue samples from 15 of the patients with the most significant symptoms of depression and 15 samples from the patients with the mildest forms of depression, the researchers then conducted whole-genome profiling to determine if the depression is linked to increased risk of death for cancer patients.

They found specific signaling pathways, which play a key role in regulating cell inflammation, were expressed at increased levels in patients with depression. The study authors concluded the link between patients' mental health and survival time is associated with inflammatory gene regulation.

"Our findings indicate that we're now able to understand some of the possible biological pathways that explain the association between depression and survival," Cohen noted.

The researchers noted that the study was limited by the fact that it's difficult to determine if patients' stress or are influenced by other factors or were present before their cancer diagnosis. While the study uncovered an association between depression and cancer survival, it did not prove a cause-and-effect relationship.

More research is needed to investigate if the treatment of depression can improve survival time among cancer patients with mild, moderate or severe mood disorders, the authors added.

Explore further: Meta-analysis: Interventions improve depression in cancer patients

More information:
The U.S. National Cancer Institute has more about cancer and depression.


Related Stories

Meta-analysis: Interventions improve depression in cancer patients

July 20, 2012
Despite guidelines recommending screening for depression in cancer patients, it's been unclear whether interventions designed to treat this depression are effective. A study by the University of Colorado Cancer Center and ...

Stigma linked to depression among lung cancer patients

March 23, 2012
Studying the role of social stigma in depression for lung cancer patients, researchers at Moffitt Cancer Center in Tampa, Fla., have found that depression can be heightened by a lung cancer patient's sense of social rejection, ...

Studies link depression, breast cancer outcomes

November 2, 2011
This year, more than 230,000 women will be diagnosed with breast cancer and nearly 40,000 women will not survive their battle with cancer, according to the American Cancer Society. New research from the University of Missouri ...

Recommended for you

Major study of genetics of breast cancer provides clues to mechanisms behind the disease

October 23, 2017
Seventy-two new genetic variants that contribute to the risk of developing breast cancer have been identified by a major international collaboration involving hundreds of researchers worldwide.

Microbiologists contribute to possible new anti-TB treatment path

October 23, 2017
As part of the long effort to improve treatment of tuberculosis (TB), microbiologists led by Yasu Morita at the University of Massachusetts Amherst report that they have for the first time characterized a protein involved ...

New study shows how cells can be led down non-cancer path

October 23, 2017
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells. In a ...

Proton therapy lowers treatment side effects in pediatric head and neck cancer patients

October 23, 2017
Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional photon radiation, and it will result in similar outcomes with less impact on quality of life. Researchers from ...

Big Data shows how cancer interacts with its surroundings

October 23, 2017
By combining data from sources that at first seemed to be incompatible, UC San Francisco researchers have identified a molecular signature in tissue adjacent to tumors in eight of the most common cancers that suggests they ...

Symptom burden may increase hospital length of stay, readmission risk in advanced cancer

October 23, 2017
Hospitalized patients with advanced cancer who report more intense and numerous physical and psychological symptoms appear to be at risk for longer hospital stays and unplanned hospital readmissions. The report from a Massachusetts ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.